Moreover, the mature active form of TGF-β can also induce the expression of some of these stromal inhibitors such as fibronectin [155] and asporin [131], further highlighting the paradox of TGF-β and the complexity of its regulation in the tumor microenvironment. The gene discussed is FN1; the disease is neoplasm.